Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Express Scripts' Shares Got Slammed

By Alex Planes - Nov 6, 2012 at 2:01PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Is this meaningful? Or just another movement?

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Prescription-drug benefits processor Express Scripts ( ESRX ) should have taken a sick day today, as its shares lost as much as 18% before settling into a 12% loss as of this writing.

So what: Although Express Scripts beat earnings estimates by $0.03 per share, its revenue came in under projections by $500 million. This wasn't the cause of the drop, as Express Scripts analysts had some uncertainty as they adjusted to the company's acquisition of rival drug-benefits company Medco Health Solutions. The big news was CEO George Paz claiming that forward expectations for next year might be too optimistic, in light of economic uncertainty heading into 2013.

The pessimistic prediction helped drag down CVS Caremark ( CVS 0.98% ), one of its most important partners. CVS had a strong report today as well, beating estimates on top and bottom lines and boosting its full-year forecast, but its shares were essentially flat this afternoon.

Now what: Investors never want to hear that their expectations for their stocks are too high, but this sounds like an indicator of broad economic weakness, rather than simply a problem with Express Scripts alone. However, Express Scripts' P/E is still a bit far from bargain territory, and with the company delaying full-year projections for 2013 to next February, it seems that the best thing for potential investors to do is be patient and dig deeper.

Want more news and updates? Add Express Scripts to your watchlist now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Express Scripts Holding Company Stock Quote
Express Scripts Holding Company
CVS Health Corporation Stock Quote
CVS Health Corporation
$90.87 (0.98%) $0.88

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/06/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.